| Title |
The Chronic Myeloid Leukemia (CML) Registry of the GQR-LMC |
| Protocole ID |
Registre LMC |
| ClinicalTrials.gov ID |
|
| Cancer Type(s) |
Chronic Myeloid Leukemia |
| Phase |
Other |
| Stage |
|
| Study Type |
|
| Drug |
|
| Institution |
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
| City |
Montréal |
| Principal Investigator |
Dr. Harold J. Olney
|
| Coordinator |
Julie Delbos
514-890-8000 poste 25385
|
| Status |
Recruiting |
| Activation Date |
18-04-2013 |
| Eligibility Criteria |
All patients in Canada who meet the following inclusion criteria may be enrolled in the CML
Registry:
- have a clinical diagnosis of CML;
- are 18 years of age or older;
- are able to give written, informed consent (or have a legal representative who can give written, informed consent when applicable).
|
| Exclusion Criteria |
Patients who meet any of the following criteria will be excluded from participation:
- unwilling or unable to give written, informed consent;
- under 18 years of age;
- life expectancy of 3 months for a condition not related to CML
|
| |
|
Groupe d'étude en oncologie du Québec